Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.67 CHF | +0.32% | -1.79% | +17.29% |
05-22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
05-22 | Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- SDZ Stock
- Revisions Sandoz Group AG